U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H5NO2
Molecular Weight 111.0987
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3,4-PYRIDINEDIOL

SMILES

OC1=C(O)C=NC=C1

InChI

InChIKey=ZCUUVWCJGRQCMZ-UHFFFAOYSA-N
InChI=1S/C5H5NO2/c7-4-1-2-6-3-5(4)8/h1-3,8H,(H,6,7)

HIDE SMILES / InChI

Molecular Formula C5H5NO2
Molecular Weight 111.0987
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood-brain barrier.
2010-08-12
Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.
2010-08
Preparation of pyridine-3,4-diols, their crystal packing and their use as precursors for palladium-catalyzed cross-coupling reactions.
2010-04-29
Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium.
2010-04
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease.
2010-02-14
The selective quantification of iron by hexadentate fluorescent probes.
2009-12-01
Combined chelation based on glycosyl-mono- and bis-hydroxypyridinones for aluminium mobilization: solution and biodistribution studies.
2009-11
Classification of 5-HT(1A) receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM.
2009-07-29
Monitoring intracellular labile iron pools: A novel fluorescent iron(III) sensor as a potential non-invasive diagnosis tool.
2009-06
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
2009-05
New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
2009-02
Synthesis of 4-pyridone-3-sulfate and an improved synthesis of 3-hydroxy-4-pyridone.
2009-01-09
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.
2009-01-08
QSAR study of antimicrobial 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives using different chemometric tools.
2008-12
Iron chelation as a potential therapy for neurodegenerative disease.
2008-12
Pyruvate carboxylase is involved in metabolism of mimosine by Rhizobium sp. strain TAL1145.
2008-10
Targeting the lysosome: fluorescent iron(III) chelators to selectively monitor endosomal/lysosomal labile iron pools.
2008-08-14
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells.
2008-06-01
Gut microbiology - broad genetic diversity, yet specific metabolic niches.
2008-05
A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
2008
55Cobalt complexes with pendant carbohydrates as potential PET imaging agents.
2007-12
Determination of the labile iron pool of human lymphocytes using the fluorescent probe, CP655.
2007-09-17
The pydA-pydB fusion gene produces an active dioxygenase-hydrolase that degrades 3-hydroxy-4-pyridone, an intermediate of mimosine metabolism.
2007-06
Multicomponent assembly of boron-based dendritic nanostructures.
2007-03-16
Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
2006-10-02
Selective determination of mimosine and its dihydroxypyridinyl derivative in plant systems.
2006-10
Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re).
2006-09-21
Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.
2006-04-01
New lipophilic 3-hydroxy-4-pyridinonate iron(III) complexes: synthesis and EXAFS structural characterisation.
2006-03-14
Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivatives.
2006-01-12
Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III).
2005-11-17
High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization.
2005-11-15
Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.
2005-08
N-Arylamine derivatives of 3-hydroxy-4-pyridinones: solution studies and bioevaluation in view of Al-detoxification roles.
2005-01
Design, synthesis and properties of novel iron(III)-specific fluorescent probes.
2004-04
Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application.
2003-09-15
The mid genes of Rhizobium sp strain TAL1145 are required for degradation of mimosine into 3-hydroxy-4-pyridone and are inducible by mimosine.
2003-02
Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.
2002-03
Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis.
2002-03
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase.
2001-12-28
Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes.
2001-12-15
Selection of several classes of mimosine-degradation-defective Tn3Hogus-insertion mutants of Rhizobium sp. strain TAL1145 on the basis of mimosine-inducible GUS activity.
2001-06
Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase.
2001-02-01
Microbial metabolism of the pyridine ring. The metabolism of pyridine-3,4-diol (3,4-dihydroxypyridine) by Agrobacterium sp.
1974-05
Microbial metabolism of the pyridine ring. The hydroxylation of 4-hydroxypyridine to pyridine-3,4-diol (3,4-dihydroxypyridine) by 4-hydroxypyridine-3-hydroxylase.
1974-05
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:09:17 GMT 2025
Edited
by admin
on Mon Mar 31 19:09:17 GMT 2025
Record UNII
UW0C50CU4H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3,4-PYRIDINEDIOL
Systematic Name English
3,4-DIHYDROXYPYRIDINE
Preferred Name English
3-HYDROXY-4(1H)-PYRIDINONE
Systematic Name English
Code System Code Type Description
CAS
1121-23-9
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
ALTERNATIVE
CHEBI
29053
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY
CHEBI
28630
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY
MESH
C007435
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID50274234
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY
CAS
10182-48-6
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY
PUBCHEM
105085
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY
FDA UNII
UW0C50CU4H
Created by admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
PRIMARY